Clinical Trials Browser

Completed × surufatinib × Thoracic × Clear all

NCT05509699 2025-08-29

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

Phase 2 Completed

Small Cell Lung Carcinoma